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A Novel Caloric Restriction-Like Mimetic Affects Longevity in Yeast by
Reprogramming Core Metabolic Pathways
Abstract
Glucose limitation is a simple intervention that extends yeast replicative lifespan (RLS) via the same
pathway(s) thought to mediate the benefits of caloric restriction (CR) in mammals. Here we report on “C1”, a
small molecule that mimics key aspects of CR. C1 was identified in a high throughput screen for drug-like
molecules that reverse the RLS shortening effect of the sirtuin inhibitor and NAD+ precursor nicotinamide.
C1 reduces the cellular dependence on glycolysis and the pentose phosphate pathway, even in the presence of
glucose, and compensates by elevating fatty acid -oxidation to maintain acetyl-CoA levels. C1 acts either
downstream of Sir2 or in an independent CR pathway. In this regard, chemical-genetic interactions indicate
that C1 influences Tor2 signaling via effects on phosphoinositide pools. Key activities of C1 extend to
mammals. C1 stimulates -oxidation in mammalian cells, and in mice, reduces levels of triacylglycerides and
cholesterol in livers of lean and obese mice. C1 confers oxidative resistance to diamide in both yeast and
mammalian cells. In conclusion, C1 induces global changes in metabolism in yeast and mammalian cells that
mimic aspects of CR. Future work will be aimed at identifying the cellular target of C1.
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C1 rescues PPP mutants
ABSTRACT:
Glucose limitation is a simple intervention that extends yeast replicative lifespan
(RLS) via the same pathway(s) thought to mediate the benefits of caloric restriction
(CR) in mammals. Here we report on “C1”, a small molecule that mimics key aspects of
CR. C1 was identified in a high throughput screen for drug-like molecules that reverse
the RLS shortening effect of the sirtuin inhibitor and NAD+ precursor nicotinamide. C1
reduces the cellular dependence on glycolysis and the pentose phosphate pathway,
even in the presence of glucose, and compensates by elevating fatty acid β-oxidation to
maintain acetyl-CoA levels. C1 acts either downstream of Sir2 or in an independent CR
pathway. In this regard, chemical-genetic interactions indicate that C1 influences Tor2
signaling via effects on phosphoinositide pools. Key activities of C1 extend to
mammals. C1 stimulates β-oxidation in mammalian cells, and in mice, reduces levels
of triacylglycerides and cholesterol in livers of lean and obese mice. C1 confers
oxidative resistance to diamide in both yeast and mammalian cells. In conclusion, C1
induces global changes in metabolism in yeast and mammalian cells that mimic
aspects of CR. Future work will be aimed at identifying the cellular target of C1.
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Conclusions:  C1is a novel bioactive small molecule that presents 
multiple phenotypes in both yeast and mammalian cells (whole animal 
and tissue culture).  The shared phenotypes of oxidative stress 
resistance, Tor interaction, and a metabolic shift toward B-oxidation of 
fatty acids suggest a conserved pathway(s) is being effected by C1.  
The phenotypes displayed by C1 treated cells are also shared by cells 
undergoing caloric restriction (CR) or contain mutations that mimic CR.  
These results suggest that C1 is acting on a pathway that is also 
effected by caloric restriction and may very well be a true CR mimetic.  
Potentially the most interesting of all the C1 results is the reduction in 
triglycerides, cholesterol and lipid storage in mammalian cells.  Such a 
compound could provide great medical benefits in the treatment of age 
related diseases such as diabetes and atherosclerosis.
The next critical step for C1 is the identification of the protein target.
C1 Rescues Pentose phosphate pathway mutants 
(CR mimicry)
C1 Reduces triglyceride, cholesterol, and fat lipid retention 
in mammalian cells
Fig 4. In a chemical genetic screen of the synthetic effects of C1, 3 deletion mutants of the
pentose phosphate pathway (gnd1∆, rpe1∆, and the double deletion of tkl1 and 2) were found
to be slow growing on galactose and rescued by C1 (A). The PPP mutants were also rescued
by caloric restriction of galactose (B) and by the double deletion of known caloric restriction
mimetics deletion mutants (C). These results show that C1 phenocopies know methods of
caloric restriction. * indicate which deletions are also resistant to diamide.
Small molecule probes reverses the lifespan shortening 
effects of nicotinamide
Fig 1. Both C1 and H7 extend the lifespan of the “DeaD” strain as compared to the vehicle control
(DMSO = 0.1%) from a nicotinamide (0.75mM) reduced lifespan (~50%). (Left) In the traditional
microdissection replicative lifespan assay using the BY4741 S. cerevisiae strain and 5mM
nicotinamide, C1 extends mean replicative lifespan by ~20% and maximum replicative lifespan by
~30%. (Right)
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Fig 2. DeaD assays using the parental, fob1∆, and sir2∆ mutants with and without nicotinamide
(NAM) at 0.75mM. Strains were treated with DMSO (0.1%) as a vehicle control or C1. Lifespan
extension due to C1 treatment was observed in the parental as well as the fob1 and sir2 deletion
strains. These data indicate that C1 does not extend lifespan by activating Sir2 or by reducing the
accumulation of ERCs. * indicates significant results t-test pvalue < 0.05.
Metabolic change due to C1 supports a shift away from 
glycolysis and the pentose phosphate pathway
C1 elevates fatty acid B-oxidation
Fig 9. C1 reduces the levels of fatty-acid oxidation intermediates. Yeast and mouse liver cells (HepG2) 
treated with C1 display decreased levels of butyryl-CoA and beta-hydroxybutyryl-CoA (BHB-CoA) 
levels as determined by qunatitative LC/MS/MS.  Other acyl-CoAs were relatively unaffected by C1 
(data not shown). These data indicate that fatty acid oxidation is affected by C1.
Fig 10. C1 reduces fat accumulation in the livers of mice fed a
standard diet (SD with 3 months C1) . Panel A shows oil-red lipid
staining of an individual SD-fed mice which did or did not receive
C1. Individual values for triacylglyceride (TAG) and
cholesterol/cholesterol-ester (Chol) levels as determined after
extraction with isopropanol and assayed with Stanbio TAG/Chol
liquicolor kits is shown above each stained panel. Panel B shows
the average TAG and Chol values (with error bars indicating
standard error) of four mice from each category (pvalues noted on
figure). Panel C shows the drastic decrease in lipid storage in
cultured pre-adipocytes treated with C1 vs. the DMSO control in a
dose dependent manner.
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rpe1∆ rescue and oxidative stress resistance are linked 
through reduced Zwf1 activity – indicating a metabolic shift
zwf1 mutants
Fig 5. (A) Spontaneous zwf1 mutants suppress the rpe1∆ growth defect and (B) confer
oxidative stress resistance. (C) Reduced ZWF1 expression rescue the rpe1∆ growth defect
and (C) confers oxidative stress resistance. (E,F) Low level ZWF1 expression is optimal for
rpe1∆ rescue and oxidative stress resistance.
Spontaneously generated zwf1 mutants rescue rpe1∆ and oxidative stress sensitivity
Reduced expression of ZWF1 rescues rpe1∆ and oxidative stress sensitivity
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C1 influences Tor2 signaling on phosphoinositide pools
(CR mimicry)
Fig 7. Chemical genetic screening of C1 with the temperature sensitive collection reveal that
C1 provides a bypass of the TORC2 complex and the required phosphoinositol metabolites
required for proper TORC2 signaling. C1 provided a growth rescue for the ts mutants of PIP
and the TORC2 complex (Green Boxes). Interestingly C1 also increased the vulnerability of ts
cells with a weakened cell wall integrity pathway. C1 was synthetic sick with these ts mutants
(red boxes). The growth inlay labeled tor2 ts and rho1ts demonstrate these synthetic effects.
Mammalian cells treated with C1 show a significant decreased in the gene expression of the
mTOR complex, linking this finding to caloric restriction.
Fig 6. C1 induced changes to the metabolic intermediates of both the pentose phosphate
pathway and glycolysis. Red circles indicate a drop in individual metabolites, green circles
indicate an increase in individual metabolites and blue circles indicate insignificant changes in
individual metabolites. Numbers in the circles describe metabolite concentration normalized to
the no C1 control. Results only suggest a change in glucose metabolism, either an increase or
decrease in flux could account for these data.
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Fig 8. The different chemical genetic screens performed with C1 provided a good deal of data
indicating which pathways were being effected. Multiple critical metabolic pathways are
influenced by C1. Of particular interest is the aforementioned pentose phosphate pathway and
glycolysis (red outline). C1 provides a rescue for slow growing mutants of the PPP, acetate
formation from pyruvate and the production of Acetyl-CoA from CoA and Acetate. Meanwhile,
C1 makes the production of Co-Enzyme A from pantothanate critical (red outline). The spot
plate growth assay inlays show the effect of C1 on the cab ts mutants and the triple deletion of
the pdc genes. These results suggest that C1 is bypassing acetyl-CoA production from glucose
fermentation and the cells compensate by liberating acetate from some other source such as
Fatty acids (green outline).
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Fig 3. Yeast strain BY 4741 treated with a variety of pro-oxidants and DMSO (0.1%) or C1
concurrently. C1 provides resistance to diamide, but induces sensitivity to paraquat and t-butyl H2O2.
(top). Mammalian tissue culture cells (pre-adipocytes and hepatocytes) treated with a variety of pro-
oxidants and DMSO or C1 concurrently. C1 provides broad, but not complete, resistance to
prooxidants in the different cell types. * indicates significance t-test pvalue < 0.05). (Bottom). CR is
known to provide resistance to oxidative stressors.
C1 provides resistance to oxidative stress (CR mimicry)
Fig 11. C1 increases fatty acid oxidation.  HepG2 were grow in media containing heavy-
labeled palmitate with increasing doses of C1 and the fraction of total acetyl-CoA derived from 
heavy palmitate was determined by LC/MS. C1 increased heavy-acetyl-CoA pool (A), whereas 
total acetyl-CoA (B) and CoA-SH (C) levels remained unchanged.  D) These data indicate 
increased beta-oxidation as a function of C1 is required for acetyl-CoA homeostasis and are 
consistent with decreased TAG levels observed in mice livers fed C1. 
C1 creates a vulnerability to reduced Co-enzyme A and a 
resistance to reduced glycolytic acetate
